Edward Hammond

13.8k total citations · 6 hit papers
164 papers, 10.3k citations indexed

About

Edward Hammond is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Edward Hammond has authored 164 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Pulmonary and Respiratory Medicine and 29 papers in Cell Biology. Recurrent topics in Edward Hammond's work include Proteoglycans and glycosaminoglycans research (27 papers), Glycosylation and Glycoproteins Research (19 papers) and Occupational and environmental lung diseases (17 papers). Edward Hammond is often cited by papers focused on Proteoglycans and glycosaminoglycans research (27 papers), Glycosylation and Glycoproteins Research (19 papers) and Occupational and environmental lung diseases (17 papers). Edward Hammond collaborates with scholars based in United States, Australia and Israel. Edward Hammond's co-authors include Irving J. Selikoff, Lawrence Garfinkel, Oscar Auerbach, Herbert Seidman, Jacob Churg, Arthur Purdy Stout, Keith Dredge, Vito Ferro, Jerome Cornfield and E. L. Wynder and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Edward Hammond

159 papers receiving 8.8k citations

Hit Papers

Smoking and Lung Cancer: Recent Evidence and a Discussion... 1958 2026 1980 2003 1959 1964 1979 1961 1958 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Hammond United States 55 3.8k 2.0k 1.4k 1.3k 1.2k 164 10.3k
Philippe Autier France 58 2.1k 0.5× 1.8k 0.9× 709 0.5× 5.6k 4.4× 1.0k 0.9× 217 14.3k
Carmen Navarro Spain 56 2.2k 0.6× 1.7k 0.8× 294 0.2× 1.5k 1.2× 612 0.5× 288 10.7k
Anthony J. Swerdlow United Kingdom 73 1.4k 0.4× 3.0k 1.5× 795 0.6× 5.6k 4.4× 798 0.7× 283 16.9k
Richard B. Johnston United States 61 1.3k 0.4× 3.0k 1.5× 287 0.2× 603 0.5× 595 0.5× 212 14.6k
Mathieu Boniol France 48 1.9k 0.5× 1.7k 0.9× 408 0.3× 5.1k 4.0× 815 0.7× 136 11.8k
Philip Cole United States 57 1.2k 0.3× 1.5k 0.7× 194 0.1× 3.7k 2.9× 1.5k 1.3× 160 11.8k
Robert E. Tarone United States 68 2.1k 0.5× 4.6k 2.3× 328 0.2× 3.7k 2.9× 1.8k 1.5× 273 16.9k
Malcolm Reed United Kingdom 52 2.8k 0.7× 1.9k 0.9× 235 0.2× 3.1k 2.5× 460 0.4× 289 9.7k
Thomas M. Mack United States 57 871 0.2× 1.5k 0.7× 287 0.2× 2.8k 2.2× 472 0.4× 187 10.3k
Gianluca Severi France 45 1.4k 0.4× 1.8k 0.9× 261 0.2× 1.6k 1.3× 736 0.6× 226 6.5k

Countries citing papers authored by Edward Hammond

Since Specialization
Citations

This map shows the geographic impact of Edward Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Hammond more than expected).

Fields of papers citing papers by Edward Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Hammond. The network helps show where Edward Hammond may publish in the future.

Co-authorship network of co-authors of Edward Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Hammond. A scholar is included among the top collaborators of Edward Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Hammond. Edward Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Upasana, Prabhu Thirusangu, Ling Jin, et al.. (2023). PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction. Oncogene. 42(37). 2725–2736. 7 indexed citations
2.
Hammond, Edward, Stefano Elli, Timothy R. Rudd, et al.. (2021). Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. Computational and Structural Biotechnology Journal. 19. 2806–2818. 34 indexed citations
3.
Hammond, Edward & Keith Dredge. (2020). Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives. Advances in experimental medicine and biology. 1221. 539–565. 12 indexed citations
4.
Hammond, Edward, Nicole M. Haynes, Carleen Cullinane, et al.. (2018). Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors. Journal for ImmunoTherapy of Cancer. 6(1). 54–54. 35 indexed citations
5.
Kundu, Soumi, Di Yu, Tommie Olofsson, et al.. (2017). Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth. Molecular Cancer Therapeutics. 16(8). 1705–1716. 30 indexed citations
6.
Roy, Debarshi, Susmita Mondal, Ashwani Khurana, et al.. (2017). Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer. Scientific Reports. 7(1). 41977–41977. 15 indexed citations
7.
Weissmann, Marina, Gil Arvatz, Netanel A. Horowitz, et al.. (2016). Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proceedings of the National Academy of Sciences. 113(3). 704–709. 89 indexed citations
8.
Shteingauz, Anna, Ilanit Boyango, Inna Naroditsky, et al.. (2015). Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Research. 75(18). 3946–3957. 130 indexed citations
9.
Boyango, Ilanit, Uri Barash, Inna Naroditsky, et al.. (2014). Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis. Cancer Research. 74(16). 4504–4514. 61 indexed citations
10.
Johnstone, Ken D., Tomislav Karoli, Ligong Liu, et al.. (2010). Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth. Journal of Medicinal Chemistry. 53(4). 1686–1699. 64 indexed citations
11.
Adamiak, Beata, Anthony C. Willis, Edward Hammond, et al.. (2005). The Synthesis and Biological Evaluation of Two Analogues of the C-Riboside Showdomycin. Australian Journal of Chemistry. 58(2). 86–93. 14 indexed citations
12.
Aken, Jan van & Edward Hammond. (2002). Closing loopholes in the biological weapons convention. Medicine Conflict & Survival. 18(2). 194–198. 2 indexed citations
13.
Selikoff, Irving J. & Edward Hammond. (1975). Toxicity of vinyl chloride-polyvinyl chloride. New York Academy of Sciences eBooks. 20 indexed citations
14.
Hammond, Edward. (1975). The epidemiological approach to the etiology of cancer. Cancer. 35(3). 652–654. 3 indexed citations
15.
Hammond, Edward. (1974). Epidemiologic basis for cancer prevention. Cancer. 33(S6). 1728–1731. 1 indexed citations
16.
Hammond, Edward. (1969). Cancer Prevention and Competitive Risks. Archives of Environmental Health An International Journal. 19(3). 395–402. 1 indexed citations
17.
Hammond, Edward. (1965). Smoking in Relation to Mortality and Morbidity.. 58(3). 40 indexed citations
18.
Hammond, Edward. (1963). Inhalation of tobacco smoke.. PubMed. 27. 473–83. 1 indexed citations
19.
Hammond, Edward. (1961). Smoking in Relation to Physical Complaints. Archives of Environmental Health An International Journal. 3(2). 146–164. 45 indexed citations
20.
Hammond, Edward. (1959). Cancer Etiology: New Prospective Epidemiological Study. CA A Cancer Journal for Clinicians. 9(5). 177–178. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026